Clinical Trial

Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal Cancer

Study acronym: Live-RF
Recruiting
View on ClinicalTrials.gov →
Summary
Combined chemotherapy and radiofrequency electromagnetic field treatment for patients with liver dominant refractory metastatic colorectal cancer
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-08-03.
Trial Details
NCT Number NCT05991102
Lead Sponsor Charite University, Berlin, Germany
Conditions Refractory Metastatic Colorectal Cancer
Enrollment 12 participants
Start Date 2023-12-15
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2023-12-21